Tambus, Allyza C.

HRN: 22-34-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
CEFUROXIME 750MG (VIAL)
12/14/2022
12/20/2022
IVT
200mg
Q8
Pcap-c
Waiting Final Action 
12/17/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
12/17/2022
12/24/2022
ORAL
1ml
QID
Oral Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: